resveratrol/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
Decreases systolic blood pressure (setting unspecified)
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Findingreplicated ×1“Subgroup analyses indicated that higher-dose of resveratrol consumption (≥ 150 mg/d) significantly reduces SBP of -11.90 mmHg (95% CI: -20.99, -2.81 mmHg, P = 0.01), whereas lower dose of resveratrol did not show a significant lowering effect on SBP.”
Quoted verbatim from Effect of resveratrol on blood pressure: a meta-analysis of randomized controlled trials.. - Study
- meta-analysis
- Dose
- ≥150 mg/day
- Population
- Meta-analysis of randomized controlled trials of resveratrol supplementation; dose-stratified subgroup receiving ≥150 mg/day resveratrol, not the full 6-trial, 247-subject pooled sample
Effect -11.9 mean difference, 95% CI -20.99 to -2.81
Effect of resveratrol on blood pressure: a meta-analysis of randomized controlled trials.2015PMID:24731650Permalink
Keep reading
- Everything the graph holds on resveratrol
- Every compound studied against Systolic blood pressure (setting unspecified)
- How to read the evidence strength and the marks
To cite this finding: https://catalystproject.ai/e/01M1ZAQEQGDM6EGSMZV15N0KTE